Cataracts

Editor's Choice

Eye care patient satisfaction is weighed with online health forums

The co-authors conducted two studies to determine patient satisfaction related to their cataract-IOL surgeries, based on online health forums.

LATEST ARTICLES

Sulcus placement of a proprietary three-piece multifocal IOL restores good outcome

Sulcus placement of a proprietary three-piece multifocal IOL (ReZoom, Abbott Medical Optics) is a viable option in eyes in which capsular bag support is not adequate to ensure good lens stability. Then, if the lens decenters in the sulcus, scleral suturing is a safe and effective option for recentering the IOL and restoring good vision.

Eye care patient satisfaction is weighed with online health forums

The co-authors conducted two studies to determine patient satisfaction related to their cataract-IOL surgeries, based on online health forums.

Microincisional IOL debuts for cataract surgery

The first microincisional IOL (Akreos MICS IOL, Bausch & Lomb) has been introduced in the U.S. market. The lens is a single-piece hydrophilic acrylic IOL designed for delivery through a 1.8-mm incision. Its material and design offer several advantages, according to three surgeons who have used it.

Dispersive-cohesive ophthalmic surgical device outperforms viscous-dispersive ophthalmic surgical device during phaco, removal

One surgeon's preference for an ophthalmic surgical device (OVD) of 1.6% sodium hyaluronate (Amvisc Plus, Bausch & Lomb) was reinforced by a study that found it superior to another OVD during phaco and OVD removal.

Ketorolac tromethamine 0.45% approved by FDA

Ketorolac tromethamine 0.45% (Acuvail, Allergan) is a preservative-free ophthalmic NSAID recently approved for twice-daily use in treating pain and inflammation after cataract surgery. Its novel formulation is designed to promote drug delivery and tolerability.